Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Samama

Showing results (481-490 of 677) with videos related to

Pageof 68
Sort By:
American Journal of Clinical Pathology|October 1, 1995
Prevalence and patient profile in activated protein C resistanceM Samaha, M Trossaert, J Conard, et al.
BMJ (Clinical Research Ed.)|October 17, 1992
Low molecular weight heparin in prevention of perioperative thrombosisA Leizorovicz, M C Haugh, F R Chapuis, et al.
Presse Medicale (Paris, France : 1983)|January 28, 1995
[Resistance to activated protein C in venous thromboembolic complications. Incidence and clinical manifestations]M Trossaërt, J Conard, M H Horellou, et al.
Thrombosis and Haemostasis|January 4, 2007
Inhibition of clot formation process by treatment with the low-molecular-weight heparin nadroparin in patients with carotid artery disease undergoing angioplasty and stenting. A thromboelastography study on whole bloodKonstantinos Konstantinidis, Thomas Gerasimidis, Elisabeth Verdy, et al.
Annales Pharmaceutiques Francaises|November 16, 2010
[Two new anticoagulants available in 2010--Dabigatran Etexilate and Rivaroxaban: expected progresses--raised problems]M Samama, J Conard, M-H Horellou, et al.
Blood|December 15, 1995
Risk of thrombosis in patients homozygous for factor V LeidenM M Samama, M Trossaërt, M H Horellou, et al.
Annales Francaises D'Anesthesie Et De Reanimation|December 3, 2014
[Efficacy and safety of tranexamic acid administration for the prevention and/or the treatment of post-partum haemorrhage: a systematic review with meta-analysis]D Faraoni, C Carlier, C M Samama, et al.
Thrombosis Research|April 15, 1987
Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challengesJ M Walenga, M Petitou, J C Lormeau, et al.
Bulletin De L'Academie Nationale De Medecine|May 1, 1997
[Comparison of two groups of 22 women homozygous or heterozygous for factor V Leiden mutation]M M Samama, J Conard, S Nassiri, et al.
European Journal of Anaesthesiology|October 5, 2010
Regional anaesthesia and antithrombotic agents: recommendations of the European Society of AnaesthesiologyWiebke Gogarten, Erik Vandermeulen, Hugo Van Aken, et al.
Pageof 68

Showing results (481-490 of 677) with videos related to

Sort By:
Pageof 68
American Journal of Clinical Pathology|October 1, 1995
Prevalence and patient profile in activated protein C resistanceM Samaha, M Trossaert, J Conard, et al.
BMJ (Clinical Research Ed.)|October 17, 1992
Low molecular weight heparin in prevention of perioperative thrombosisA Leizorovicz, M C Haugh, F R Chapuis, et al.
Presse Medicale (Paris, France : 1983)|January 28, 1995
[Resistance to activated protein C in venous thromboembolic complications. Incidence and clinical manifestations]M Trossaërt, J Conard, M H Horellou, et al.
Thrombosis and Haemostasis|January 4, 2007
Inhibition of clot formation process by treatment with the low-molecular-weight heparin nadroparin in patients with carotid artery disease undergoing angioplasty and stenting. A thromboelastography study on whole bloodKonstantinos Konstantinidis, Thomas Gerasimidis, Elisabeth Verdy, et al.
Annales Pharmaceutiques Francaises|November 16, 2010
[Two new anticoagulants available in 2010--Dabigatran Etexilate and Rivaroxaban: expected progresses--raised problems]M Samama, J Conard, M-H Horellou, et al.
Blood|December 15, 1995
Risk of thrombosis in patients homozygous for factor V LeidenM M Samama, M Trossaërt, M H Horellou, et al.
Annales Francaises D'Anesthesie Et De Reanimation|December 3, 2014
[Efficacy and safety of tranexamic acid administration for the prevention and/or the treatment of post-partum haemorrhage: a systematic review with meta-analysis]D Faraoni, C Carlier, C M Samama, et al.
Thrombosis Research|April 15, 1987
Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challengesJ M Walenga, M Petitou, J C Lormeau, et al.
Bulletin De L'Academie Nationale De Medecine|May 1, 1997
[Comparison of two groups of 22 women homozygous or heterozygous for factor V Leiden mutation]M M Samama, J Conard, S Nassiri, et al.
European Journal of Anaesthesiology|October 5, 2010
Regional anaesthesia and antithrombotic agents: recommendations of the European Society of AnaesthesiologyWiebke Gogarten, Erik Vandermeulen, Hugo Van Aken, et al.
Pageof 68